We are live on
!
Find out more
Cogent Biosciences
COGT
COGT
267 hedge funds and large institutions have $6.18B invested in Cogent Biosciences in 2025 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 93 increasing their positions, 64 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
352% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 21
170% more capital invested
Capital invested by funds: $2.29B → $6.18B (+$3.9B)
108% more funds holding in top 10
Funds holding in top 10: 12 → 25 (+13)
45% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 64
37% more funds holding
Funds holding: 195 → 267 (+72)
28% more call options, than puts
Call options by funds: $23.8M | Put options by funds: $18.6M
17.58% less ownership
Funds ownership: 139.85% → 122.27% (-18%)
Holders
267
Holders Change
+72
Holders Change %
+36.92%
% of All Funds
3.25%
Holding in Top 10
25
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+108.33%
% of All Funds
0.3%
New
95
Increased
93
Reduced
64
Closed
21
Calls
$23.8M
Puts
$18.6M
Net Calls
+$5.23M
Net Calls Change
-$7.69M
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$116M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$106M |
| 3 |
BlackRock
New York
|
+$73.2M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$69.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$64.8M |
Top Sellers
| 1 |
CC
Commodore Capital
New York
|
-$142M |
| 2 |
VA
VR Adviser
New York
|
-$56.2M |
| 3 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$48.4M |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$45.3M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$44.7M |
